Rapid deployment of vaccine facilities
The global vaccine market has seen significant growth due to the growing global population, increased immunisation coverage and new vaccines being introduced. With COVID-19 this trend is expected to accelerate. The billions of doses of COVID-19 vaccine required on top of the existing vaccine demand is just one of the dynamics influencing capacity planning for manufacturers. New treatments and more approvals every year, in particular biological drugs, also add to the global capacity demand.
To manage the situation, pharmaceutical companies continuously assess options for balancing available capacity by adding more capacity. For the short term, they can increase outsourcing to Contract Manufacturing Organisations (CMOs) or repurpose existing facilities. Looking beyond the short term, they can alternatively plan to build new facilities.
Rapid deployment of vaccine facilities
The global vaccine market has seen significant growth due to the growing global population, increased immunisation coverage and new vaccines being introduced. With COVID-19 this trend is expected to accelerate. The billions of doses of COVID-19 vaccine required on top of the existing vaccine demand is just one of the dynamics influencing capacity planning for manufacturers. New treatments and more approvals every year, in particular biological drugs, also add to the global capacity demand.
To manage the situation, pharmaceutical companies continuously assess options for balancing available capacity by adding more capacity. For the short term, they can increase outsourcing to Contract Manufacturing Organisations (CMOs) or repurpose existing facilities. Looking beyond the short term, they can alternatively plan to build new facilities.